In her first piece on our site, Charlotte G. wrote about how her experience with her mother's cancer and her own BRCA2 diagnosis shapes her approach to cancer care. "My takeaway is that people are generally more at ease when they feel that you can truly relate to their experience. Certainly, as nurses, we cannot possibly endure all the ailments and strife our patients go through, but if it just so happens that we did have that experience, should we share it? For me, the answer often is yes. By understanding where they are coming from, I have been able to take better care of my patients, anticipate their needs, and provide support. Through self-disclosure, I have formed more intimate connections that make my patients and their loved ones feel less alone."
Oncology Nursing News
Book and Periodical Publishing
Cranbury, NJ 2,701 followers
Capturing the voice of nursing professionals in the oncology news landscape.
About us
Through our print magazine, which appears 6 times a year, and our dynamic website, Oncology Nursing News provides the latest news and clinical insights for oncology nursing professionals. Online, we also feature live coverage from major oncology meetings, video interviews, and blog posts from your peers. As we move ahead, we will continually look for new and better ways to get oncology news to you as quickly and efficiently as possible. Subscribe to our magazine, email newsletter, Facebook, Twitter, and/or Instagram feeds to stay up to date on important news in your field and read advice from fellow nurses. It is an exciting time for cancer research and treatment, and we look forward to Bringing the Oncology Nursing Community Together.
- Website
-
https://www.oncnursingnews.com/
External link for Oncology Nursing News
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Cranbury, NJ
- Type
- Privately Held
Locations
-
Primary
Cranbury, NJ 08512, US
Updates
-
Oncology Nursing News' Community Case Forum is coming to Orlando, FL on July 30! If you are a nurse practitioner or physician assistant in the Orlando area, join us for networking and a case-based discussion on multiple myeloma. Don't miss this opportunity to enhance your practice! Register here: https://ow.ly/M2OT50Su1wE
-
-
In this month's Rx Road Map, Sri Kota, MSN, BA, APN, AGNP-C, AOCNP, of Rutgers Cancer Institute provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.
Rx Road Map: Enfortumab Vedotin (Padcev)
oncnursingnews.com
-
The Summer 2024 issue of Oncology Nursing News® has arrived, packed with inspiring stories and valuable insights for oncology professionals. Discover how Meaghan Mooney, Chief of Staff at Ascension Medical Group, is making a difference in the lives of poor and vulnerable patients. Explore the impactful work of Wonders & Worries, a nonprofit offering crucial support to children and teens affected by cancer in their families. Learn how to celebrate the "little victories" during challenging times. This issue is filled with articles that highlight the compassionate side of oncology care and provide practical resources for nurses and healthcare providers. Don't miss out on these touching stories and expert perspectives – grab your copy of Oncology Nursing News® today at https://ow.ly/hgkg50SsZzr #OncologyProfessionals #NurseResources #OncologyCare #CancerSupport
-
-
The undiagnosed clinic allows APPs to be autonomous and flexible and use their knowledge to provide the latest evidence-based care for their patient population, ultimately leading to an expedited workup and diagnosis. https://lnkd.in/enpyVSe4
Undiagnosed Clinic—Meeting the Needs of Patients With Incidental Findings
oncnursingnews.com
-
The FDA approved the ready-to-dilute formulation of Tepylute for breast and ovarian cancers, which can help to reduce prep time and provide more accurate dosing.
FDA Approves Tepylute to Treat Breast, Ovarian Cancers
oncnursingnews.com
-
An accelerated approval has been granted by the FDA to epcoritamab-bysp (Epkinly) for adult patients with relapsed or refractory follicular lymphoma after 2 or more lines of systemic therapy.
FDA Approves Epcoritamab for Relapsed/Refractory Follicular Lymphoma
oncnursingnews.com
-
The administration of CAR T-cell therapy in an outpatient setting was deemed feasible and safe for patients with relapsed/refractory non-Hodgkin lymphoma. #EHA2024
Outpatient CAR T-Cell Therapy May Be Safe, Feasible for Relapsed/Refractory Non-Hodgkin Lymphoma
oncnursingnews.com
-
Accelerated approval has been granted to adagrasib for use with cetuximab in previously treated adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer.
FDA Approves Adagrasib for KRAS G12C-Mutated Metastatic Colorectal Cancer
oncnursingnews.com
-
Calling Advanced Practice Providers in the Houston area! Join us for an evening of insight & networking at the Community Case Forum. Dive into "Bispecific Therapy in Relapsed/Refractory Multiple Myeloma" with Tiffany Richards from MD Anderson Cancer Center. 📅 July 22, 2024 📍Houston, TX. Learn more and register: https://lnkd.in/e5hA36Zs #Oncology #NetworkingEvent #HoustonEvents
-